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With Electric-Field Guided rTMS for
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Stefan Schoisswohl*, Berthold Langguth and Martin Schecklmann
Department of Psychiatry and Psychotherapy, University of Regensburg, Regensburg, Germany
Background: Past research highlighted the benefits of personalized repetitive
transcranial magnetic stimulation (rTMS) for the treatment of chronic subjective tinnitus.
Objective/Hypothesis: The objective was to investigate the feasibility of rTMS
personalization by identifying individually optimal stimulation parameters in test sessions.
Particularly, effectiveness and retest–reliability of different stimulation parameters
were examined.
Methods: Via electric-field guided rTMS, five patients were stimulated with different
frequencies on three positions of the left and right superior temporal gyrus on 2
separate days. After each stimulation, the patients had to evaluate tinnitus loudness and
discomfort of the used protocol.
Results: Individualization of rTMS was possible in all five patients. Significant lower
tinnitus loudness was found for 1Hz stimulation. Positive correlations between 2 days
were observed for hemisphere (left, right), position (mSTG, pSTG), and frequency (1, 10,
20Hz). High-frequency stimulation produced high discomfort.
Conclusion: Personalization of rTMS is considered as feasible. Consistency of
parameter-specific tinnitus suppression is demonstrated.
Keywords: repetitive transcranial magnetic stimulation, tinnitus, neuronavigation, individualized treatment,
personalized medicine
INTRODUCTION
Current research findings in the field of neurostimulation and tinnitus are still ambiguous
with respect to the effectiveness of repetitive transcranial magnetic stimulation (rTMS) for the
treatment of chronic subjective tinnitus (1). It remains unclear which stimulation parameters, e.g.,
stimulation positions or frequencies, are most effective. To combat this uncertainty and also to
enhance the potential efficacy of rTMS for tinnitus, two promising approaches are provided by
the personalization of rTMS treatments. First, usage of neuronavigation or electric-field (e-field)
guided rTMS is a putative candidate as coil positions can be defined and tracked in the range of
mms over the intended target area by means of individual anatomical MRI scans (2, 3). Second,
during test sessions using short stimulations with reduced number of pulses, several different
frequencies and positions can be tested in order to detect a patient-specific rTMS protocol for the
most appropriate short-term tinnitus suppression. Compared to other neuropsychiatric disorders
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like depression, tinnitus offers the advantage of an immediate
response to an intervention - namely changes in tinnitus
loudness. The possibility to briefly suppress tinnitus by single-
session rTMS for a short period of time is considered as feasible
(4). Identified protocols can then be used for daily treatment.
The approach to focus on individual results in tinnitus research
(in this case, patient-specific rTMS protocols for short-term
tinnitus suppression) was already emphasized by Tyler et al.
(5). So far, the concept of rTMS personalization has only been
examined in a study by Kreuzer et al. (6). Patients were stimulated
throughout test sessions with 1-, 5-, 10-, and 20Hz, continuous
theta burst stimulation along with a sham condition (200 or
50 pulses each) over the left and right dorsolateral prefrontal
cortex and left and right temporoparietal junction on both
hemispheres. Responders (sham-controlled and stimulation-
specific reductions) were identified and stimulated with their
most effective prefrontal and temporoparietal rTMS protocol
over the course of a 2 week period (4,000 pulses per session).
Non-responders received the standard stimulation protocol for
the particular brain region. Better improvements in tinnitus-
related questionnaires were found for the group that received
individualized treatment as compared to the group receiving
the standard protocol. This confirms the ability to identify
personalized rTMS protocols and suggests the superiority of this
approach for the treatment of chronic tinnitus with rTMS.
Following on from the findings of this study, the hereafter
reported feasibility trial investigates whether it is possible to
personalize e-field guided rTMS and examines the effectiveness
and retest–reliability of certain stimulation parameters in short-
term tinnitus suppression. For this purpose, three different
stimulation positions of the left and right superior temporal gyrus
(STG) are stimulated by an e-field guided neuronavigation rTMS
system with different frequency protocols on two different days.
MATERIALS AND METHODS
Sample Characteristics
Five patients (1 female) with chronic subjective tinnitus (>6
months tinnitus duration) and rTMS experience were enrolled
in this feasibility trial. The mean age was 51.6 years (SD= 10.92),
all of them were right-handers, two experienced unilateral right-
sided tinnitus, whereas three suffered from bilateral tinnitus.
Primary inclusion criteria were as follows: age 18–75; subjective
chronic tinnitus; no serious medical, neurological, or psychiatric
disorders; stable medication; no contraindication for magnetic
resonance imaging (MRI); no current tinnitus treatment or
participation in other tinnitus-related experiments. All patients
gave written informed consent prior to the experiment.
rTMS Test Session
T1-weighted MRI brain scans conducted by a MAGNETOM
1.5-T scanner (Siemens, Germany) preceded the experiment.
Individual anatomical images in combination with an e-field
guided neuronavigation rTMS system (NBT System 2; Nexstim
Plc., Finland) facilitated a stimulation of the patients’ STG with
millimeter accuracy. Besides visualization and information on
the strength of the induced e-field (V/m) in real time, the
usage of an e-field guided rTMS system offered the opportunity
to control for the direction of the induced electric current
[for a detailed description of e-field guided rTMS, see (7)].
Before the test sessions, the patients’ resting motor threshold
(RMT) was defined via the stimulation of the left primary motor
cortex and simultaneous recordings of motor evoked potentials
(MEPs) from the thenar muscles of the right hand. Individual
motor hotspots were detected by the administration of single
pulses (maximum 30 pulses) over different positions of the left
primary motor cortex, until several MEPs with a peak-to-peak
amplitude of >50 µV were detectable. The position with the
highest amplitude threshold was repeated with the aid of an
aiming tool implemented in the neuronavigation system (same
coil orientation and tilting). Subsequently, RMT determination
was performed by applying single pulses with automatically
varying intensity shifts (2.5% steps up and down). The RMT
was specified as the minimum stimulation intensity needed to
produce MEPs with a minimum of 50 µV amplitude in at least
50% of applied pulses.
Six stimulation positions for rTMS were localized in reference
to Sahlsten et al. (3). Stimulation positions consisted of anterior
(aSTG), middle (mSTG), and posterior (pSTG) parts of the left
and right STG. Anterior parts were localized about 1 cm in
posterior direction from the junction of sulcus centralis with the
STG. PSTG was set at the temporoparietal junction, whereas the
mSTG was selected in the middle of those two points. During
the test sessions, patients were stimulated with 200 pulses of
1-, 10-, 20-, and 0.1Hz (20 pulses, active control condition, no
neuroplastic effects expected due to few pulses and long pulse
intervals) rTMS with 110% RMT.
Each stimulation was executed with the coil placed in such a
way that the direction of the induced e-field was perpendicular to
the sulcus of the target area. The order of stimulation frequency,
hemisphere, and positions was randomized. After each of the 24
protocols, the patients had to rate the loudness of their tinnitus on
a numeric rating scale from 0 to 110% of baseline loudness (0%
represents a total absence of tinnitus, 100% no change in tinnitus
loudness, whereas 110% signified an increase in the tinnitus
loudness by 10%) and the degree of discomfort from 0 to 10 (10
signified intolerability) induced by the rTMS interventions. To
investigate reliability, the test session was repeated on a second
day with a minimum interval of 1 day and a new randomization
(in addition reversed order of hemisphere). The most suitable
rTMS protocol for short-term tinnitus suppression was identified
individually for each patient with respect to the induced tinnitus
loudness reduction as well as discomfort rating of the respective
rTMS protocol.
Statistical Analysis
Tinnitus loudness ratings for all patients were averaged for the
stimulation parameters frequency, position, and hemisphere
and analyzed with the statistic software SPSS (SPSS ver. 24;
IBM, USA). Differences in tinnitus loudness and discomfort
ratings for stimulation positions and frequencies were analyzed
by Friedmann tests. Significant effects were followed up by
Wilcoxon tests. Wilcoxon tests were conducted to examine
differences in the stimulation hemisphere. Reliability of
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stimulation parameters in short-term tinnitus suppression (day
1 and day 2) was analyzed by Kendall’s Tau correlations with
averaging the parameters of non-interest. Statistical significance
was set at p ≤ 0.05. Plots were created in R (R version 3.4.3;
TABLE 1 | Individual rTMS protocol per patient.
Patient no.
1 2 3 4 5
Stimulation intensity (%) 36 24 51 30 30
Hemisphere Right Left Left Right Right
Position mSTG pSTG pSTG aSTG pSTG
Frequency (Hz) 1 1 10 1 1
Tinnitus loudness (%
from baseline loudness)
80 90 50 80 50
Discomfort rating of
rTMS protocol
3 1 3 2 0
R Foundation for Statistical Computing, Austria) with the
package “ggplot2.”
RESULTS
As shown in Table 1, an individual best protocol for brief tinnitus
suppression could be identified for each patient. Statistical
analysis showed a significant effect of frequency [χ2(3) = 9.98,
p = 0.02]. Post hoc tests revealed significant lower tinnitus
loudness ratings of 1Hz compared to 0.1Hz (z = −2.02, p
= 0.04), 10Hz (z = −2.02, p = 0.04), as well as 20Hz (z =
−2.02, p = 0.04) with no differences between the other contrasts
(all p-values > 0.05). No significant effects were found for
stimulation position [χ2(5) = 1.60, p = 0.45] and hemisphere
(z = −0.67, p = 0.50) (compare Figures 1A,D,G). Statistical
tests for the discomfort ratings exposed a significant effect of
frequency [χ2(5) = 9.98, p = 0.02]. Post hoc Wilcoxon tests
revealed significant differences between 0.1 and 1Hz (z=−2.04,
p = 0.04), 0.1 and 10Hz, 0.1 and 20Hz, 1 and 10Hz, as well as 1
and 20Hz (z = −2.02, p = 0.04). The sham condition followed
FIGURE 1 | Tinnitus loudness and discomfort ratings. Tinnitus loudness and discomfort ratings for rTMS parameters stimulation frequency (A,B), stimulation position
(D,E), and stimulation hemisphere (G,H) are illustrated. Error bars represent standard deviations. Significant differences (p < 0.05) are highlighted by *. Reliability
results for the 2 days are outlined in (C,F,I). Tinnitus amelioration lies within the gray rectangle. Tinnitus loudness ratings for rTMS over the aSTG for day 2 are missing
for one patient due to painfulness.
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by 1Hz produced the least discomfort ratings. Further analysis
indicated significant lower discomfort levels for left hemispheric
rTMS (z=−2.02, p = 0.04). Near-significant differences were
found for the stimulation positions [χ2(5) = 5.20, p = 0.07]
(compare Figures 1B,E,H). Tests for loudness rating reliability
discovered a positive correlation between day 1 and day 2 for
the left and right hemispheres (rτ = 0.80, p = 0.05) and also for
the stimulation positions mSTG (rτ = 0.80, p = 0.05) and pSTG
(rτ = 1.00, p = 0.05). Likewise, significant positive correlations
were found for the frequencies 1Hz (rτ = 0.80, p = 0.05),
10Hz (rτ = 0.80, p = 0.05), and 20Hz (rτ = 0.95, p = 0.05).
Figures 1C,F,I illustrate individual tinnitus loudness ratings for
stimulation frequency, position, and hemisphere over the 2 days.
CONCLUSION
The aim of this study was to examine if a personalization of rTMS
with e-field guided neuronavigation is feasible and reliable. We
tested the impact of various stimulation parameters (position,
frequency, and hemisphere) on short-term tinnitus suppression.
Since none of the patients reported superior tinnitus reduction
for the sham condition, together with the possibility to identify
an individual protocol for each patient, customization of rTMS
protocols by performing test sessions with different protocols is
considered as feasible.
With respect to retest–reliability for stimulation parameters,
we demonstrated consistent tinnitus loudness ratings for
hemisphere (left, right), stimulation position (mSTG, pSTG),
and frequency (1, 10, 20Hz) in tinnitus suppression. Therefore,
the consistency of parameter-specific tinnitus suppression can
be assumed.
We also observed a significant group effect of the protocol
with superior effects for 1Hz suggesting the superiority of 1Hz
over the other tested frequencies (10, 20Hz) as a general effect,
which does not depend on individual differences in susceptibility
to rTMS effects.
Discomfort ratings indicate that stimulations over the aSTG
(one patient dropout; aSTG < mSTG < pSTG) of the
right hemisphere and with high-frequency protocols (0.1 <
1 < 10 < 20Hz) as most unpleasant. These discoveries
underline the usefulness of test sessions in order to identify
an rTMS protocol with the best tolerability and the best
tinnitus suppression. On the other hand, the influence of
local side effects on loudness reduction cannot be excluded.
The cooling noise of the TMS coil made it rather difficult
for some patients to accurately rate loudness changes of
their tinnitus during the test sessions. It is conceivable that
tinnitus loudness ratings and thereby parameter effectiveness
would be different with a silent coil. Since the same coil
was used for the whole trial, reliability results should not be
affected. However, future test session trials should strive for
bigger sample sizes and implementation of silent or uncooled
TMS coils, and focus either on other brain regions or one
stimulation position to tackle the huge testable parameter space
in rTMS.
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